Elutia (ELUT) Cash & Equivalents Growth (3y) (2022 - 2026)
Elutia (ELUT) Cash & Equivalents Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.57 Bn | 193.97 Bn | 7.27 Bn | -13.31% |
| 2 | Stryker | 127.25 Bn | 123.77 Bn | 4.50 Bn | 34.27% |
| 3 | Medtronic | 118.81 Bn | 109.59 Bn | 6.41 Bn | 8.10% |
| 4 | Boston Scientific | 73.35 Bn | 72.81 Bn | 3.85 Bn | 8.16% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 40.74% |
| 6 | Dexcom | 34.28 Bn | 32.34 Bn | 830.00 Mn | -2.57% |
| 7 | GE HealthCare Technologies | 33.75 Bn | 31.64 Bn | 2.18 Bn | 2.72% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 38.28% |
| 9 | Steris | 23.03 Bn | 22.55 Bn | 684.20 Mn | 32.23% |
| 10 | Elutia | 39.84 Mn | 19.94 Mn | 1.45 Mn | 28.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.19% |
| Dec 31, 2025 | 28.86% |
| Sep 30, 2025 | -16.47% |
| Jun 30, 2025 | -19.82% |
| Mar 31, 2025 | -7.69% |
| Dec 31, 2024 | -24.20% |
| Sep 30, 2024 | 4.52% |
| Jun 30, 2024 | -13.70% |
| Mar 31, 2024 | -25.55% |
| Dec 31, 2023 | -21.04% |
| Sep 30, 2023 | 111.06% |
| Jun 30, 2023 | 110.97% |
| Mar 31, 2023 | 179.14% |
| Dec 31, 2022 | 89.87% |
| Sep 30, 2022 | 209.59% |